Gainers
- Ensysce Biosciences ENSC stock increased by 47.9% to $0.31 during Wednesday's pre-market session. The company's market cap stands at $11.8 million.
- TransCode Therapeutics RNAZ shares moved upwards by 36.11% to $1.47. The market value of their outstanding shares is at $19.0 million.
- Accuray ARAY shares moved upwards by 25.6% to $2.6. The company's market cap stands at $243.3 million.
- Adverum Biotechnologies ADVM stock increased by 16.3% to $1.07. The company's market cap stands at $106.2 million.
- Cosmos Holdings COSM shares moved upwards by 14.43% to $0.1. The market value of their outstanding shares is at $8.8 million.
- Geovax Labs GOVX stock moved upwards by 14.21% to $1.0. The company's market cap stands at $24.6 million.
Losers
- ThermoGenesis Holdings THMO shares fell 46.7% to $0.12 during Wednesday's pre-market session. The company's market cap stands at $3.7 million.
- Revelation Biosciences REVB stock declined by 19.69% to $0.33. The company's market cap stands at $7.7 million.
- Taysha Gene Therapies TSHA shares fell 15.44% to $2.52. The company's market cap stands at $103.5 million.
- Ocuphire Pharma OCUP stock declined by 14.6% to $1.99. The market value of their outstanding shares is at $40.9 million.
- Calyxt CLXT shares fell 11.46% to $0.15. The company's market cap stands at $7.0 million.
- Summit Therapeutics SMMT shares decreased by 9.74% to $1.02. The market value of their outstanding shares is at $205.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ARAYAccuray Inc
$1.943.74%
COSMCosmos Health Inc
$0.65706.31%
ENSCEnsysce Biosciences Inc
$10.1522.9%
GOVXGeovax Labs Inc
$2.283.17%
REVBRevelation Biosciences Inc
$0.32206.48%
RNAZTransCode Therapeutics Inc
$3.51-1.86%
SMMTSummit Therapeutics Inc
$19.001.77%
THMOThermoGenesis Holdings Inc
$0.00060-%
TSHATaysha Gene Therapies Inc
$1.840.54%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in